Stock-Based Compensation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | 9 Months Ended |
Sep. 30, 2015 | Sep. 30, 2014 | Sep. 30, 2015 | Sep. 30, 2014 |
Stock based compensation by job function [Line Items] | | | | | |
Common Shares Available for Grant | | 24,600 | | 24,600 | |
Compensation expense related to the company's stock-based compensation plans | | $ 40.3 | $ 38.5 | $ 102 | $ 103.6 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | 20 | 21.2 | 43.3 | 44.9 |
Lease And Well [Member] | | | | | |
Stock based compensation by job function [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 10.3 | 9.7 | 32.9 | 30.4 |
Gathering And Processing Costs [Member] | | | | | |
Stock based compensation by job function [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 0.4 | 0.4 | 1 | 0.9 |
Exploration Costs [Member] | | | | | |
Stock based compensation by job function [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 6 | 6.7 | 19.3 | 20.2 |
General And Administrative [Member] | | | | | |
Stock based compensation by job function [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 23.6 | $ 21.7 | $ 48.8 | $ 52.1 |
Stock Options and SARs [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 21.87 | $ 30.77 |
Expected Volatility (in hundredths) | | | | 38.04% | 35.25% |
Risk-Free Interest Rate (in hundredths) | | | | 0.83% | 0.95% |
Dividend Yield (in hundredths) | | | | 0.85% | 0.60% |
Expected Life (in years) | | | | 5 years 3 months 18 days | 5 years 2 months 12 days |
Stock Options and SARs Rollforward [Abstract] | | | | | |
Outstanding at January 1 (in shares) | | | | 10,493 | 10,452 |
Granted (in shares) | | | | 2,029 | 2,122 |
Exercised (1) (in shares) | [1] | | | (1,291) | (1,351) |
Forfeited (in shares) | | | | (203) | (226) |
Outstanding at September 30 (2) (in shares) | [2] | 11,028 | 10,997 | 11,028 | 10,997 |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 64.96 | $ 54.43 |
Granted (price per share) | | | | 69.95 | 101.65 |
Exercised (1) (price per share) | [1] | | | 47.25 | 44.52 |
Forfeited (price per share) | | | | 80.12 | 62.95 |
Outstanding at September 30 (2) (price per share) | [2] | $ 67.67 | $ 64.58 | $ 67.67 | $ 64.58 |
Stock Options and SARs Vested or Expected to Vest (in shares) | [3] | 10,653 | 10,568 | 10,653 | 10,568 |
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) | [3] | $ 67.22 | $ 63.92 | $ 67.22 | $ 63.92 |
Stock Options and SARs Exercisable at September 30 (in shares) | [4] | 6,121 | 5,573 | 6,121 | 5,573 |
Stock Options and SARs Exercisable at September 30 (price per share) | [4] | $ 57.34 | $ 49.23 | $ 57.34 | $ 49.23 |
Intrinsic value of stock options/SARs exercised during the period | [1] | | | $ 52.4 | $ 78 |
Aggregate intrinsic value for outstanding stock options and SARs | [2] | $ 136.9 | $ 384.9 | $ 136.9 | $ 384.9 |
Weighted average remaining contractual life for stock options/SARs outstanding (in years) | | | | 4 years 4 months 24 days | 4 years 7 months 6 days |
Aggregate intrinsic value of stock options/SARs vested or expected to vest | [3] | 135.7 | 376.6 | $ 135.7 | $ 376.6 |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) | | | | 4 years 3 months 18 days | 4 years 6 months |
Aggregate intrinsic value for exercisable units | [4] | 121.6 | 277.5 | $ 121.6 | $ 277.5 |
Weighted average remaining contractual life for exercisable options/SARs (in years) | | | | 3 years 1 month 6 days | 3 years 3 months 18 days |
Unrecognized compensation expense | | 112.2 | | $ 112.2 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 3 years | |
ESPP [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 21.40 | $ 21.27 |
Expected Volatility (in hundredths) | | | | 32.54% | 25.12% |
Risk-Free Interest Rate (in hundredths) | | | | 0.12% | 0.08% |
Dividend Yield (in hundredths) | | | | 0.72% | 0.50% |
Expected Life (in years) | | | | 6 months | 6 months |
Restricted Stock and Restricted Stock Units [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Unrecognized compensation expense | | 194.5 | | $ 194.5 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 8 months 12 days | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | | $ 16.2 | $ 13.9 | $ 53.9 | $ 53.4 |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 5,394 | 7,358 |
Granted (in shares) | | | | 1,036 | 1,024 |
Released (in shares) | [5] | | | (1,250) | (2,540) |
Forfeited (in shares) | | | | (152) | (220) |
Outstanding at September 30 (1) (in shares) | [6] | 5,028 | 5,622 | 5,028 | 5,622 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 64.39 | $ 49.54 |
Granted (price per share) | | | | 77.90 | 99 |
Released (price per share) | [5] | | | 51.02 | 37.92 |
Forfeited (price per share) | | | | 74.83 | 59.36 |
Outstanding at September 30 (1) (price per share) | [6] | $ 70.18 | $ 63.41 | $ 70.18 | $ 63.41 |
Intrinsic value of restricted stock and restricted stock units released during the year | [5] | | | $ 102.5 | $ 270 |
Aggregate intrinsic value of stock and units outstanding | [6] | $ 366 | $ 556.7 | $ 366 | $ 556.7 |
Performance Units and Performance Stock [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 80.64 | $ 119.27 |
Expected Volatility (in hundredths) | | | | 29.35% | 32.18% |
Risk-Free Interest Rate (in hundredths) | | | | 1.07% | 1.18% |
Term Of Zero- Coupon Risk- Free Interest Rate In Years Derived From Treasury Constant Maturities Yield Curve | | | | 3 years 3 months 4 days | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Unrecognized compensation expense | | $ 6.4 | | $ 6.4 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 3 years 6 months | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 333 | 261 |
Granted (in shares) | | | | 72 | 72 |
Released (in shares) | | | | 0 | 0 |
Forfeited (in shares) | | | | 0 | 0 |
Outstanding at September 30 (1) (in shares) | [7] | 405 | 333 | 405 | 333 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 90.17 | $ 82.18 |
Granted (price per share) | | | | 80.64 | 119.27 |
Released (price per share) | | | | 0 | 0 |
Forfeited (price per share) | | | | 0 | 0 |
Outstanding at September 30 (1) (price per share) | [7] | $ 88.48 | $ 90.17 | $ 88.48 | $ 90.17 |
Aggregate intrinsic value of stock and units outstanding | [7] | $ 29.5 | $ 33 | $ 29.5 | $ 33 |
Performance Units and Performance Stock [Abstract] | | | | | |
Share-Based Compensation Arrangement By Performance Units and Performance Stock Compensation Cost | | $ 4.1 | $ 3.4 | $ 4.8 | $ 5.3 |
| |
[1] | The total intrinsic value of stock options/SARs exercised for the nine months ended September 30, 2015 and 2014 was $52.4 million and $78.0 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at September 30, 2015 and 2014 was $136.9 million and $384.9 million, respectively. At September 30, 2015 and 2014, the weighted average remaining contractual life was 4.4 years and 4.6 years, respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2015 and 2014 was $135.7 million and $376.6 million, respectively. At September 30, 2015 and 2014, the weighted average remaining contractual life was 4.3 years and 4.5 years, respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at September 30, 2015 and 2014 was $121.6 million and $277.5 million, respectively. At September 30, 2015 and 2014, the weighted average remaining contractual life was 3.1 years and 3.3 years, respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released for the nine months ended September 30, 2015 and 2014 was $102.5 million and $270.0 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2015 and 2014 was $366.0 million and $556.7 million, respectively. | |
[7] | The total intrinsic value of performance units and performance stock outstanding at September 30, 2015 and 2014 was $29.5 million and $33.0 million, respectively. | |